Johnson & Johnson (J&J) has now confirmed that it is buying the medical device maker, Synthes. The purchase price is $21.3 billion in cash and stock, in one of the biggest deals ever in the healthcare sector. The rumors of the acquisition began swirling last week. Synthes will join with the J&J unit of DePuy Companies. It [...]
Johnson & Johnson to Buy Medical Device Company Synthes
April 21, 2011 By 1 Comment
The rumors began over the weekend and are growing stronger. Johnson & Johnson (J&J) is in discussion to acquire Synthes, a Swiss medical device manufacturer. If the deal crystallizes, J&JÂ could boost its revenue and profit in the short term and gain a strong foothold in the growing market for orthopedic surgery products. It will also [...]
GAO Concerned About Medical Device Approval Process
April 20, 2011 By Leave a Comment
The Government Accountability Office (GAO) has raised concerns about the approval process that high-risk medical devices undergo — or rather, don’t undergo — by the U.S. Food and Drug Administration (FDA). The federal watchdog group says the agency recently took steps to see if certain high-risk medical devices, such as artificial hips and external defibrillators, [...]
FDA Steps In At Johnson and Johnson Over Product Recalls
March 16, 2011 By 1 Comment
By now, Johnson & Johnson (J&J) executives are probably wishing that their baby shampoo slogan “No More Tears” applied to their recent encounters with the U.S. Food and Drug Administration (FDA). The FDA is stepping in at three Johnson & Johnson manufacturing plants after the company put out a slew of recalls of its products [...]
